Received Jan 20, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 3 | 646907 | IM / RA |
Patient came to clinic requesting Hep B vaccine. Discussed this would be 3rd Hep B vaccine. Patient voiced "Yeah. I don't know the kind I had for the first one." Patient received Heplisav at Health Department on 12/18/2025 as 2nd dose of Hep B. Followed nursing protocol to complete series of Hep B with Heplisav due to unknown dose 1 for Hep B. Heplisav administered. Patient tolerated well. Patient instructed to wait on site for 15 minutes prior to leaving. Patient voiced no concerns.
Patient did not report illness.
Unknown.
Unknown.
No Known Allergies.
N/A